Fisher Asset Management
IGC icon

Fisher Asset Management’s IGC Pharma IGC Stock Holding History

Fisher Asset Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Hold
43,400
– – ﹤0.01% 1035
2026
Q1 		$11.4K Hold
43,400
– – ﹤0.01% 1013
2025
Q4 		$12.2K Hold
43,400
– – ﹤0.01% 1014
2025
Q3 		$18.1K Buy
+43,400
New +$16.5K ﹤0.01% 1011

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Fisher Asset Management's IGC Position: Q2 2026 in Review

Fisher Asset Management held its IGC Pharma (IGC) position steady in Q2 2026 at 43,400 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Fisher Asset Management first reported a position in IGC in Q3 2025 and has held it in 4 quarters since. The position peaked at $18.1K in Q3 2025. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Fisher Asset Management held 43,400 shares of IGC Pharma worth $11.8K as of Q2 2026.
  • Fisher Asset Management left its IGC Pharma share count unchanged in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #1035 holding.
  • Fisher Asset Management first reported a position in IGC Pharma in Q3 2025 and has held it in 4 quarters since.
  • Fisher Asset Management's IGC Pharma position peaked at $18.1K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.